Dual CD44–Golgi targeting lipid nanoparticles for metabolic reprogramming and precision mitoxantrone delivery in Triple-Negative Breast Cancer
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Cancer
Hypoxia
and Metabolism
Publication details
- Journal / source
- Chemical Engineering Journal
- Publisher
- Elsevier BV
- Volume
- 528
- Pages
- 172476–172476
- Publication date
- 1 January 2026
- Language
- EN